NeoPharm CO., LTD. (KOSDAQ:092730)
South Korea flag South Korea · Delayed Price · Currency is KRW
13,460
+340 (2.59%)
Apr 1, 2025, 3:30 PM KST

NeoPharm CO., LTD. Revenue

In the year 2024, NeoPharm CO., LTD. had annual revenue of 119.01B KRW with 22.56% growth. NeoPharm CO., LTD. had revenue of 34.03B in the quarter ending December 31, 2024, with 25.04% growth.

Revenue
119.01B
Revenue Growth
+22.56%
P/S Ratio
1.77
Revenue / Employee
672.39M
Employees
177
Market Cap
210.53B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024119.01B21.91B22.56%
Dec 31, 202397.10B12.07B14.20%
Dec 31, 202285.03B-2.90B-3.30%
Dec 31, 202187.93B6.31B7.72%
Dec 31, 202081.63B-1.61B-1.94%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
KT&G Corporation 5,908.79B
Amorepacific 3,885.11B
Samyang Foods 1,728.02B
LG H&H 6,811.92B
ORION 3,104.34B
CJ Cheiljedang 29.36T
Dong Suh Companies 488.86B
APR Co., Ltd. 722.75B
Revenue Rankings